Table 3.
Treatment group | Low (n = 34) | Medium (n = 35) | High (n = 27) | ||||||
---|---|---|---|---|---|---|---|---|---|
Greene’s Climacteric Scale | Baseline | Week 12 | Change from baseline | Baseline | Week 12 | Change from baseline | Baseline | Week 12 | Change from baseline |
Psychological score | 18.29 ± 4.00a | 17.47 ± 4.37 | − 0.83 ± 5.10 | 18.51 ± 4.92 | 16.40 ± 4.11 | − 2.11 ± 4.19 | 17.02 ± 3.55 | 15.93 ± 3.59 | − 1.10 ± 3.89 |
Vasomotor score | 4.46 ± 1.58 | 3.97 ± 1.73 | − 0.49 ± 1.18 | 4.50 ± 1.54 | 3.49 ± 1.27 | − 1.01 ± 1.84 | 3.54 ± 1.22 | 3.37 ± 1.69 | − 0.17 ± 2.02 |
Somatic score | 9.79 ± 1.81 | 9.29 ± 2.28 | − 0.49 ± 2.50 | 9.71 ± 2.30 | 9.49 ± 2.13 | − 0.23 ± 2.68 | 9.77 ± 2.64 | 9.26 ± 3.37 | − 0.51 ± 3.52 |
Total score | 34.72 ± 5.37 | 32.76 ± 6.52 | − 1.96 ± 6.83 | 34.87 ± 7.31 | 31.29 ± 6.10 | − 3.58 ± 6.87 | 32.52 ± 6.42 | 30.52 ± 7.91 | − 2.00 ± 8.62 |
No significant differences were observed between the groups for any of the symptoms assessed as determined using a Kruskal–Wallis test
aMean ± SD (all such values)